Clinical Trial Update: NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial comparing trastuzumab-deruxtecan against chemotherapy with trastuzumab and pertuzumab in HER2-positive early breast cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)
• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: West German Study Group | Conditions: HER2-positive Early Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING